Actively Recruiting
Non-Invasively Re-Training the Tinnitus Brain Using Bimodal Electrical-Sound Stimulation (NITESGON-ADT): Protocol for a Prospective, Double-Blind, Randomised Controlled Trial
Led by University of Dublin, Trinity College · Updated on 2026-04-03
100
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a new approach to reduce tinnitus loudness and distress in adults with chronic tonal tinnitus. The study tests non-invasive electrical stimulation of the greater occipital nerve (NITESGON) combined with an attention-demanding auditory frequency discrimination training task. Conducted as a double-blind, placebo-controlled trial at Trinity College Dublin, the study involves 100 adults randomized into four groups to compare real versus sham stimulation and active versus passive listening. Participants receive eight sessions over four weeks, with two sessions each week. The interventions include real or sham NITESGON delivered via electrodes on the neck while participants either actively engage in auditory training or passively listen during a visual task. Each session lasts about 45 minutes. The study measures tinnitus loudness, functional impact, and handicap, among other auditory and physiological outcomes. Throughout the study, participants undergo assessments at baseline, after treatment, and at 28 days and 6 months post-treatment. Evaluations include tinnitus loudness scales, questionnaires, hearing tests, speech-in-noise performance, EEG recordings, heart rate, saliva biomarkers, and quality of life measures. Safety and blinding are monitored during the treatment period. The total participation spans several months with follow-up visits to track long-term effects.
CONDITIONS
Brief Title
Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 80 years
- Continuous subjective tinnitus lasting more than 3 months and up to 5 years
- Predominantly tonal tinnitus in one or both ears
- Screening Tinnitus Handicap Inventory score between 28 and 76
- Minimum Masking Level between 20 and 80 dB HL
- No previous neuromodulation treatment for tinnitus
- Able to complete eight sessions over four weeks and all follow-up visits
You will not qualify if you...
- Objective or predominantly somatic tinnitus
- Pulsatile tinnitus
- Conductive hearing loss detected by ear exam or tympanometry
- Hearing loss greater than 40 dB HL at 250 Hz to 1 kHz or greater than 80 dB HL at 2 to 8 kHz in either ear
- Hearing aid use started within the last 90 days
- Active implantable medical devices like pacemakers or cochlear implants
- Loudness discomfort level below 30 dB SL at 500 Hz in either ear
- Temporomandibular joint disorder or occipital neuralgia
- Severe anxiety (STAI score over 120)
- Cognitive impairment (MMSE score below 25)
- Severe depression (BDI score 30 or higher)
- Menière's disease diagnosis
- Current pregnancy
- Involvement in medicolegal cases
- History of auditory hallucinations
- Current use of certain central nervous system drugs affecting neuromodulation
- Participation in another interventional study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants receive bimodal electrical-sound stimulation combined with auditory or visual tasks during eight sessions over four weeks.
8 sessions (2 per week, in-person)
Duration - 6 months post-treatment
Participants return for assessments of tinnitus and related outcomes up to 6 months after treatment completion.
3 visits (end of treatment, 28 days post-treatment, and 6 months post-treatment)
Trial Site Locations
Total: 1 location
1
Trinity College Institute of Neuroscience (TCIN)
Dublin, Dublin, Ireland, D02
Actively Recruiting
Research Team
S
Sven Vanneste, PhD
A
Anusha Mohan, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here